Determination of the substrate specificities of N-acetyl-D-glucosaminyltransferase

被引:40
作者
Chen, Miao
Bridges, Arlene
Liu, Jian [1 ]
机构
[1] Univ N Carolina, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA
关键词
D O I
10.1021/bi060844g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparan sulfate plays a wide range of physiological and pathological roles. Heparan sulfate consists of glucosamine and glucuronic/iduronic acid repeating disaccharides with various sulfations. Synthesis of structurally defined heparan sulfate oligosaccharides remains a challenge. Access to nonsulfated and unepimerized heparan sulfate backbone structures represents an essential step toward de novo enzymatic synthesis of heparan sulfate. The nonsulfated, unepimerized backbone heparan sulfate is similar to the capsular polysaccharide from Escherichia coli strain K5. The biosynthesis of this capsular polysaccharide involves in N-acetylglucosaminyltransferase (KfiA) and D-glucuronyltransferase ( KfiC). In this study, we report the characterization of purified KfiA. KfiA was expressed in a C-terminal six-His fusion protein in BL21 star cells coexpressing chaperone proteins GroEL and GroES. The recombinant KfiA was purified to homogeneity with a Ni-agarose column. The binding affinities of various UDP-sugars for KfiA were determined using isothermal calorimetry titration, indicating that both the N-acetyl group and sugar type may be essential for donor substrates to bind KfiA. Kinetic analysis of KfiA toward different sizes of oligosaccharide revealed that KfiA is less sensitive to the size of the acceptor substrates. The results from this study open a new approach for the synthesis of the heparan sulfate backbone.
引用
收藏
页码:12358 / 12365
页数:8
相关论文
共 28 条
[1]   Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties [J].
Avci, FY ;
Karst, NA ;
Linhardt, RJ .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (28) :2323-2335
[2]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[3]   Enzymatic redesigning of biologically active heparan sulfate [J].
Chen, JH ;
Avci, FY ;
Muñoz, EM ;
McDowell, LM ;
Chen, M ;
Pedersen, LC ;
Zhang, LJ ;
Linhardt, RJ ;
Liu, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :42817-42825
[4]   Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D [J].
DeAngelis, PL ;
White, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) :7209-7213
[5]   Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2 [J].
Duncan, MB ;
Liu, M ;
Fox, C ;
Liu, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (04) :1232-1237
[6]   The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5 [J].
Duncan, MB ;
Chen, JH ;
Krise, JP ;
Liu, J .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2004, 1671 (1-3) :34-43
[7]   Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1 [J].
Edavettal, SC ;
Lee, KA ;
Negishi, M ;
Linhardt, RJ ;
Liu, J ;
Pedersen, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) :25789-25797
[8]   Order out of chaos: Assembly of ligand binding sites in heparan sulfate [J].
Esko, JD ;
Selleck, SB .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :435-471
[9]   Molecular diversity of heparan sulfate [J].
Esko, JD ;
Lindahl, U .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) :169-173
[10]   Role of the carbohydrate binding site of the Streptococcus pneumoniae capsular polysaccharide type 3 synthase in the transition from oligosaccharide to polysaccharide synthesis [J].
Forsee, WT ;
Cartee, RT ;
Yother, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (10) :6283-6289